AIP
DRUG

Ameritas Investment Partners’s Bright Minds Biosciences DRUG Stock Holding History

Ameritas Investment Partners’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.3K Hold
470
– – ﹤0.01% 2318
2025
Q4 		$36.7K Hold
470
– – ﹤0.01% 2332
2025
Q3 		$28.5K Hold
470
– – ﹤0.01% 2508
2025
Q2 		$12.3K Buy
+470
New +$14.1K ﹤0.01% 2898

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ameritas Investment Partners's DRUG Position: Q1 2026 in Review

Ameritas Investment Partners held its Bright Minds Biosciences (DRUG) position steady in Q1 2026 at 470 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Ameritas Investment Partners first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. The position peaked at $36.7K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Ameritas Investment Partners held 470 shares of Bright Minds Biosciences worth $34.3K as of Q1 2026.
  • Ameritas Investment Partners left its Bright Minds Biosciences share count unchanged in Q1 2026.
  • Bright Minds Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2318 holding.
  • Ameritas Investment Partners first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Ameritas Investment Partners's Bright Minds Biosciences position peaked at $36.7K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.